Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2012

01.05.2012 | Retinal Disorders

Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study

verfasst von: Rasmus Ejstrup, M. la Cour, S. Heegaard, J. F. Kiilgaard

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

This study introduces a novel porcine model to examine the histopathological and electrophysiological consequences of retinotoxicity exerted by dyes commonly used for internal limiting membrane (ILM) staining.

Methods

Indocyanine green (ICG) 0.5 mg/ml, Brilliant Blue G (BBG) 0.25 mg/ml and triamcinolone acetonide (TA) 13 mg/ml was injected subretinally in 12 vitrectomized pig eyes. At 6 weeks, retinas were examined by multifocal electroretinography (mfERG), ophthalmoscopy, fluorescein angiograpy, histopathology, and apoptosis assay.

Results

mfERG responses were significantly lower in ICG-injected eyes than in healthy fellow eyes (p = 0.039). The ratio between injected eyes and healthy fellow eyes was lower in the ICG group than in the BBG (p = 0.009) and TA group (p = 0.025). No difference between BBG and TA existed. All retinas were reattached, and fluorescein angiographies showed a window defect corresponding to the injected areas but no blood–retina barrier break-down. Histopathology confirmed damage to the outer retina after ICG, but not after BBG and TA. No apoptosis was found at 6 weeks.

Conclusions

Subretinal ICG induces histological and functional damage to the retina, suggesting that ICG should be used with caution in macular hole surgery, where subretinal migration can occur. In contrast, BBG and TA appear safe after subretinal injection.
Literatur
1.
Zurück zum Zitat Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107:2010–2014PubMedCrossRef Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107:2010–2014PubMedCrossRef
2.
Zurück zum Zitat Farah ME, Maia M, Rodrigues EB (2009) Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 148:332–340PubMedCrossRef Farah ME, Maia M, Rodrigues EB (2009) Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 148:332–340PubMedCrossRef
3.
Zurück zum Zitat Stanescu-Segall D, Jackson TL (2009) Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye 23:504–518PubMedCrossRef Stanescu-Segall D, Jackson TL (2009) Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye 23:504–518PubMedCrossRef
4.
Zurück zum Zitat Kiilgaard JF, Nissen MH, la Cour M (2006) An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 84:42–46PubMedCrossRef Kiilgaard JF, Nissen MH, la Cour M (2006) An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 84:42–46PubMedCrossRef
5.
Zurück zum Zitat Hirata A, Inomata Y, Kawaji T, Tanihara H (2003) Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy. Am J Ophthalmol 136:353–355PubMedCrossRef Hirata A, Inomata Y, Kawaji T, Tanihara H (2003) Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy. Am J Ophthalmol 136:353–355PubMedCrossRef
6.
Zurück zum Zitat Czajka MP, McCuen BW, Cummings TJ, Nguyen H, Stinnett S, Wong F (2004) Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 24:275–282PubMedCrossRef Czajka MP, McCuen BW, Cummings TJ, Nguyen H, Stinnett S, Wong F (2004) Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 24:275–282PubMedCrossRef
7.
Zurück zum Zitat Beutel J, Dahmen G, Ziegler A, Hoerauf H (2007) Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 125:326–332PubMedCrossRef Beutel J, Dahmen G, Ziegler A, Hoerauf H (2007) Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 125:326–332PubMedCrossRef
8.
Zurück zum Zitat Christensen UC, Kroyer K, Sander B, Larsen M, Henning V, Villumsen J, la Cour M (2009) Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol 93:1005–1015PubMedCrossRef Christensen UC, Kroyer K, Sander B, Larsen M, Henning V, Villumsen J, la Cour M (2009) Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol 93:1005–1015PubMedCrossRef
9.
Zurück zum Zitat Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG (2007) Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245:973–979PubMedCrossRef Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG (2007) Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245:973–979PubMedCrossRef
10.
Zurück zum Zitat Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T (2006) Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 26:623–630PubMedCrossRef Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T (2006) Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 26:623–630PubMedCrossRef
11.
Zurück zum Zitat Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T (2006) Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 26:631–636PubMedCrossRef Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T (2006) Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 26:631–636PubMedCrossRef
12.
Zurück zum Zitat Remy M, Thaler S, Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Gruterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C (2008) An in vivo evaluation of brilliant blue G in animals and humans. Br J Ophthalmol 92:1142–1147PubMedCrossRef Remy M, Thaler S, Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Gruterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C (2008) An in vivo evaluation of brilliant blue G in animals and humans. Br J Ophthalmol 92:1142–1147PubMedCrossRef
13.
Zurück zum Zitat Enaida H, Ishibashi T (2008) Brilliant blue in vitreoretinal surgery. Dev Ophthalmol 42:115–125PubMedCrossRef Enaida H, Ishibashi T (2008) Brilliant blue in vitreoretinal surgery. Dev Ophthalmol 42:115–125PubMedCrossRef
14.
Zurück zum Zitat Maia M, Farah ME, Rodrigues EB, Malerbi FK (2009) Subretinal brilliant blue G migration during internal limiting membrane peeling. Br J Ophthalmol 93:1687PubMedCrossRef Maia M, Farah ME, Rodrigues EB, Malerbi FK (2009) Subretinal brilliant blue G migration during internal limiting membrane peeling. Br J Ophthalmol 93:1687PubMedCrossRef
15.
Zurück zum Zitat Ueno A, Hisatomi T, Enaida H, Kagimoto T, Mochizuki Y, Goto Y, Kubota T, Hata Y, Ishibashi T (2007) Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 27:499–504PubMedCrossRef Ueno A, Hisatomi T, Enaida H, Kagimoto T, Mochizuki Y, Goto Y, Kubota T, Hata Y, Ishibashi T (2007) Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 27:499–504PubMedCrossRef
16.
Zurück zum Zitat Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M (2005) Triamcinolone-assisted internal limiting membrane peeling. Retina 25:972–975PubMedCrossRef Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M (2005) Triamcinolone-assisted internal limiting membrane peeling. Retina 25:972–975PubMedCrossRef
17.
Zurück zum Zitat Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47:722–728PubMedCrossRef Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47:722–728PubMedCrossRef
18.
Zurück zum Zitat Yu SY, Damico FM, Viola F, D'Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26:531–536PubMedCrossRef Yu SY, Damico FM, Viola F, D'Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26:531–536PubMedCrossRef
19.
Zurück zum Zitat Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84:342–348PubMedCrossRef Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84:342–348PubMedCrossRef
20.
Zurück zum Zitat Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, Takasu I, Ohtsuki H (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 28:427–432PubMedCrossRef Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, Takasu I, Ohtsuki H (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 28:427–432PubMedCrossRef
21.
Zurück zum Zitat Kyhn MV, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2008) Functional implications of short-term retinal detachment in porcine eyes: study by multifocal electroretinography. Acta Ophthalmol (Oxf) 86:18–25CrossRef Kyhn MV, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2008) Functional implications of short-term retinal detachment in porcine eyes: study by multifocal electroretinography. Acta Ophthalmol (Oxf) 86:18–25CrossRef
22.
Zurück zum Zitat Ejstrup R, Kiilgaard JF, Tucker BA, Klassen HJ, Young MJ, la Cour M (2010) Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs. Exp Eye Res 91:890–895PubMedCrossRef Ejstrup R, Kiilgaard JF, Tucker BA, Klassen HJ, Young MJ, la Cour M (2010) Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs. Exp Eye Res 91:890–895PubMedCrossRef
23.
Zurück zum Zitat Ejstrup R, Scherfig E, la Cour M (2011) Electrophysiological consequences of experimental branch retinal vein occlusion in pigs and the effect of dorzolamide. Invest Ophthalmol Vis Sci 52:952–958PubMedCrossRef Ejstrup R, Scherfig E, la Cour M (2011) Electrophysiological consequences of experimental branch retinal vein occlusion in pigs and the effect of dorzolamide. Invest Ophthalmol Vis Sci 52:952–958PubMedCrossRef
24.
Zurück zum Zitat Kyhn MV, Warfvinge K, Scherfig E, Kiilgaard JF, Prause JU, Klassen H, Young M, la Cour M (2009) Acute retinal ischemia caused by controlled low ocular perfusion pressure in a porcine model. Electrophysiological and histological characterisation. Exp Eye Res 88:1100–1106PubMedCrossRef Kyhn MV, Warfvinge K, Scherfig E, Kiilgaard JF, Prause JU, Klassen H, Young M, la Cour M (2009) Acute retinal ischemia caused by controlled low ocular perfusion pressure in a porcine model. Electrophysiological and histological characterisation. Exp Eye Res 88:1100–1106PubMedCrossRef
25.
Zurück zum Zitat Saikia P, Maisch T, Kobuch K, Jackson TL, Baumler W, Szeimies RM, Gabel VP, Hillenkamp J (2006) Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 47:4998–5003PubMedCrossRef Saikia P, Maisch T, Kobuch K, Jackson TL, Baumler W, Szeimies RM, Gabel VP, Hillenkamp J (2006) Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 47:4998–5003PubMedCrossRef
26.
Zurück zum Zitat Ferencz M, Somfai GM, Farkas A, Kovacs I, Lesch B, Recsan Z, Nemes J, Salacz G (2006) Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 142:765–770PubMedCrossRef Ferencz M, Somfai GM, Farkas A, Kovacs I, Lesch B, Recsan Z, Nemes J, Salacz G (2006) Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 142:765–770PubMedCrossRef
27.
Zurück zum Zitat Horio N, Horiguchi M (2004) Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 122:992–996PubMedCrossRef Horio N, Horiguchi M (2004) Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 122:992–996PubMedCrossRef
28.
Zurück zum Zitat Kawaji T, Hirata A, Inomata Y, Koga T, Tanihara H (2004) Morphological damage in rabbit retina caused by subretinal injection of indocyanine green. Graefes Arch Clin Exp Ophthalmol 242:158–164PubMedCrossRef Kawaji T, Hirata A, Inomata Y, Koga T, Tanihara H (2004) Morphological damage in rabbit retina caused by subretinal injection of indocyanine green. Graefes Arch Clin Exp Ophthalmol 242:158–164PubMedCrossRef
29.
Zurück zum Zitat Penha FM, Maia M, Farah ME, Dib E, Principe AH, Devin F, Rodrigues EB, Duprat JP, Freymuller E (2008) Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits. J Ocul Pharmacol Ther 24:52–61PubMedCrossRef Penha FM, Maia M, Farah ME, Dib E, Principe AH, Devin F, Rodrigues EB, Duprat JP, Freymuller E (2008) Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits. J Ocul Pharmacol Ther 24:52–61PubMedCrossRef
30.
Zurück zum Zitat Penha FM, Maia M, Eid FM, Principe AH, Freymuller EH, Maia A, Magalhaes O Jr, Smith RL (2007) Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 114:899–908PubMedCrossRef Penha FM, Maia M, Eid FM, Principe AH, Freymuller EH, Maia A, Magalhaes O Jr, Smith RL (2007) Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 114:899–908PubMedCrossRef
31.
Zurück zum Zitat Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS (2004) Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 24:80–91PubMedCrossRef Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS (2004) Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 24:80–91PubMedCrossRef
32.
Zurück zum Zitat Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY (2003) Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina 23:675–681PubMedCrossRef Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY (2003) Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina 23:675–681PubMedCrossRef
33.
Zurück zum Zitat Sato Y, Tomita H, Sugano E, Isago H, Yoshida M, Tamai M (2006) Evaluation of indocyanine green toxicity to rat retinas. Ophthalmologica 220:153–158PubMedCrossRef Sato Y, Tomita H, Sugano E, Isago H, Yoshida M, Tamai M (2006) Evaluation of indocyanine green toxicity to rat retinas. Ophthalmologica 220:153–158PubMedCrossRef
34.
Zurück zum Zitat Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, Au Eong KG, Farah ME, Fujii GY, Weiland J, de Juan E Jr, D'Anna SA, Humayun MS (2004) Effects of intravitreal indocyanine green injection in rabbits. Retina 24:69–79PubMedCrossRef Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, Au Eong KG, Farah ME, Fujii GY, Weiland J, de Juan E Jr, D'Anna SA, Humayun MS (2004) Effects of intravitreal indocyanine green injection in rabbits. Retina 24:69–79PubMedCrossRef
35.
Zurück zum Zitat Goldstein M, Zemel E, Loewenstein A, Perlman I (2006) Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 47:2100–2107PubMedCrossRef Goldstein M, Zemel E, Loewenstein A, Perlman I (2006) Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 47:2100–2107PubMedCrossRef
36.
Zurück zum Zitat Creuzot-Garcher C, Acar N, Passemard M, Bidot S, Bron A, Bretillon L (2010) Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina. Retina 30:1294–1301PubMedCrossRef Creuzot-Garcher C, Acar N, Passemard M, Bidot S, Bron A, Bretillon L (2010) Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina. Retina 30:1294–1301PubMedCrossRef
37.
Zurück zum Zitat Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME (2007) Vital dyes for chromovitrectomy. Curr Opin Ophthalmol 18:179–187PubMedCrossRef Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME (2007) Vital dyes for chromovitrectomy. Curr Opin Ophthalmol 18:179–187PubMedCrossRef
38.
Zurück zum Zitat Rodrigues EB, Penha FM, Farah ME, de Paula F, Costa E, Maia M, Dib E, Bottos J, Freymuller E, Furlani B, Meyer CH, Magalhaes O Jr, Lima-Filho AA, Safatle A (2009) Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 29:497–510PubMedCrossRef Rodrigues EB, Penha FM, Farah ME, de Paula F, Costa E, Maia M, Dib E, Bottos J, Freymuller E, Furlani B, Meyer CH, Magalhaes O Jr, Lima-Filho AA, Safatle A (2009) Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 29:497–510PubMedCrossRef
39.
Zurück zum Zitat Luke M, Januschowski K, Beutel J, Luke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P (2008) Electrophysiological effects of brilliant blue G in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Exp Ophthalmol 246:817–822PubMedCrossRef Luke M, Januschowski K, Beutel J, Luke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P (2008) Electrophysiological effects of brilliant blue G in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Exp Ophthalmol 246:817–822PubMedCrossRef
40.
Zurück zum Zitat Ueno A, Enaida H, Hata Y, Hisatomi T, Nakamura T, Mochizuki Y, Sakamoto T, Ishibashi T (2007) Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study. Eur J Ophthalmol 17:392–398PubMed Ueno A, Enaida H, Hata Y, Hisatomi T, Nakamura T, Mochizuki Y, Sakamoto T, Ishibashi T (2007) Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study. Eur J Ophthalmol 17:392–398PubMed
41.
Zurück zum Zitat Haritoglou C, Yu A, Freyer W, Priglinger SG, Alge C, Eibl K, May CA, Welge-Luessen U, Kampik A (2005) An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 46:3315–3322PubMedCrossRef Haritoglou C, Yu A, Freyer W, Priglinger SG, Alge C, Eibl K, May CA, Welge-Luessen U, Kampik A (2005) An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 46:3315–3322PubMedCrossRef
42.
Zurück zum Zitat Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K (2007) Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 38:365–370PubMed Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K (2007) Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 38:365–370PubMed
43.
Zurück zum Zitat Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA (2005) Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112:593–598PubMedCrossRef Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA (2005) Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112:593–598PubMedCrossRef
44.
Zurück zum Zitat Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, Yokoyama M, Furukawa M, Sonoda Y, Yamada T, Doi N, Enaida H, Hata Y, Ishibashi T (2007) Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 114:289–296PubMedCrossRef Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, Yokoyama M, Furukawa M, Sonoda Y, Yamada T, Doi N, Enaida H, Hata Y, Ishibashi T (2007) Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 114:289–296PubMedCrossRef
45.
Zurück zum Zitat Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A (2003) Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110:604–608PubMedCrossRef Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A (2003) Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110:604–608PubMedCrossRef
46.
Zurück zum Zitat Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y (2003) Retention of dye after indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 136:172–174PubMedCrossRef Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y (2003) Retention of dye after indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 136:172–174PubMedCrossRef
47.
Zurück zum Zitat Engel E, Schraml R, Maisch T, Kobuch K, Konig B, Szeimies RM, Hillenkamp J, Baumler W, Vasold R (2008) Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci 49:1777–1783PubMedCrossRef Engel E, Schraml R, Maisch T, Kobuch K, Konig B, Szeimies RM, Hillenkamp J, Baumler W, Vasold R (2008) Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci 49:1777–1783PubMedCrossRef
48.
Zurück zum Zitat Schmidt LC, Steffansen B, Scherfig E, la Cour M (2005) Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs. Acta Ophthalmol Scand 83:184–190CrossRef Schmidt LC, Steffansen B, Scherfig E, la Cour M (2005) Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs. Acta Ophthalmol Scand 83:184–190CrossRef
49.
Zurück zum Zitat Simoens P, De Schaepdrijver L, Lauwers H (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. A: morphology of the retinal microvasculature. Exp Eye Res 54:965–973PubMedCrossRef Simoens P, De Schaepdrijver L, Lauwers H (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. A: morphology of the retinal microvasculature. Exp Eye Res 54:965–973PubMedCrossRef
50.
Zurück zum Zitat De Schaepdrijver SL, Simoens P, Pollet L, Lauwers H, De Laey JJ (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. B: fluorescein angiography of the retina. Exp Eye Res 54:975–985PubMedCrossRef De Schaepdrijver SL, Simoens P, Pollet L, Lauwers H, De Laey JJ (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. B: fluorescein angiography of the retina. Exp Eye Res 54:975–985PubMedCrossRef
51.
Zurück zum Zitat Chandler MJ, Smith PJ, Samuelson DA, MacKay EO (1999) Photoreceptor density of the domestic pig retina. Vet Ophthalmol 2:179–184PubMedCrossRef Chandler MJ, Smith PJ, Samuelson DA, MacKay EO (1999) Photoreceptor density of the domestic pig retina. Vet Ophthalmol 2:179–184PubMedCrossRef
52.
Zurück zum Zitat Wang M, Sander B, la Courla M, Larsen M (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83:691–696PubMedCrossRef Wang M, Sander B, la Courla M, Larsen M (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83:691–696PubMedCrossRef
53.
Zurück zum Zitat Immel J, Negi A, Marmor MF (1986) Acute changes in RPE apical morphology after retinal detachment in rabbit. A SEM study. Invest Ophthalmol Vis Sci 27:1770–1776PubMed Immel J, Negi A, Marmor MF (1986) Acute changes in RPE apical morphology after retinal detachment in rabbit. A SEM study. Invest Ophthalmol Vis Sci 27:1770–1776PubMed
54.
Zurück zum Zitat Voss KM, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2007) The multifocal electroretinogram (mfERG) in the pig. Acta Ophthalmol Scand 85:438–444CrossRef Voss KM, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2007) The multifocal electroretinogram (mfERG) in the pig. Acta Ophthalmol Scand 85:438–444CrossRef
55.
Zurück zum Zitat Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43:1673–1685PubMed Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43:1673–1685PubMed
56.
Zurück zum Zitat Ng YF, Chan HH, Chu PH, Siu AW, To CH, Beale BA, Gilger BC, Wong F (2008) Pharmacologically defined components of the normal porcine multifocal ERG. Doc Ophthalmol 116:165–176PubMedCrossRef Ng YF, Chan HH, Chu PH, Siu AW, To CH, Beale BA, Gilger BC, Wong F (2008) Pharmacologically defined components of the normal porcine multifocal ERG. Doc Ophthalmol 116:165–176PubMedCrossRef
Metadaten
Titel
Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study
verfasst von
Rasmus Ejstrup
M. la Cour
S. Heegaard
J. F. Kiilgaard
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2012
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1886-3

Weitere Artikel der Ausgabe 5/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.